Home / Health / Injectable Drugs Recalled Over Glass, Metal Fears
Injectable Drugs Recalled Over Glass, Metal Fears
28 Aug
Summary
- Baxter International recalled two nutritional and one anticoagulant injection.
- Potential fiberglass and metal particle contamination identified.
- Injections could cause blockages, clotting, and tissue injury.
Baxter International Inc. has initiated a voluntary recall of three injectable medications, citing concerns over potential contamination with fiberglass and stainless steel particles. The affected products include two injections for providing nutrition, water, and electrolytes, and one anticoagulant.
The contamination poses significant health risks, including the possibility of blood vessel blockages, clotting issues, and potential tissue or organ injury. The Food and Drug Administration confirmed these recalls in notices published on August 25 and August 26.
The recalled 70% Dextrose Injection, used for intravenous nutrition, was distributed between July 25 and July 28 to healthcare providers and distributors in Alabama, Georgia, and Tennessee. Separately, the 0.9% Sodium Chloride Injection, used for hydration and as a procedural fluid, was distributed between July 31 and August 3 to several states including Florida, Illinois, and New York.
These medications, packaged in Viaflex plastic containers, could be present in healthcare facilities, distributors, and home healthcare settings. Consumers with recalled products are advised not to use them and to return them to the facility from which they were obtained. Baxter is contacting customers with specific identification and return instructions.
